Showing 14 of 14 recruiting trials for “Rare malignant epithelial tumor of liver and intrahepatic biliary tract”
Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
👨⚕️ Madison Conces, MD, Case Comprehensive Cancer Center, University Hospitals📍 2 sites📅 Started Dec 2025View details ↗
Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
RecruitingNCT07151118 ↗
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
RecruitingNCT07142226 ↗
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer
RecruitingNCT06793709 ↗
A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
HX009+ IN10018 with or Without Standard Chemotherapy for Advanced Solid Tumours
👨⚕️ Lin Shen, Peking University Cancer Hospital & Institute📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06653127 ↗
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance
Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)
DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
👨⚕️ Vikas Ostwal, DM, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India 400012📍 6 sites📅 Started Jul 2023View details ↗
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
👨⚕️ Li-Tzong Chen, Ph.D, National Institute of Cancer Research📍 5 sites📅 Started Mar 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →